ERVW-1 and lung adenocarcinoma: Taken together, these results indicate that expression of Env from its cognate LTR-enhancer can induce lung adenocarcinomas comprised of alveolar type II cells in immunocompetent mice and that despite a robust antibody-mediated immune response against Env, tumorigenesis cannot be controlled by the normal immune system of these mice.